A Rare Presentation of Extramedullary Hematopoiesis in Post-polycythemic Myelofibrosis

被引:0
作者
Ceyla Konca Degertekin
Zübeyde Nur Özkurt
Nalan Akyürek
Münci Yağcı
机构
[1] Gazi University Faculty of Medicine,Department of Endocrinology and Metabolism
[2] Gazi University Faculty of Medicine,Department of Hematology, Department of Internal Medicine
[3] Gazi University Faculty of Medicine,Department of Pathology
来源
Indian Journal of Hematology and Blood Transfusion | 2014年 / 30卷
关键词
Polycythemia vera; Myelofibrosis; Extramedullary hematopoiesis; Skin; Splenectomy; Heart;
D O I
暂无
中图分类号
学科分类号
摘要
Polycythemia vera is a clonal proliferative disorder of the bone marrow that could possibly evolve into myelofibrosis in its natural course. Progression to myelofibrosis is usually a late stage complication and presents clinically with refractory cytopenias and extramedullary hematopoiesis (EMH). EMH can occur in any tissue during the course of post-polycythemic myelofibrosis. However, skin and cardiac involvements seems to be very rare. We present a 56-year-old woman with post-polycythemic myelofibrosis refractory to treatment, developing EMH after splenectomy in various organs, exceptionally the skin and the heart. Along with the case, the clinical presentations, treatment options, prognostic significance of EMH and the role of cytogenetics is discussed in the light of the literature.
引用
收藏
页码:12 / 16
页数:4
相关论文
共 226 条
  • [1] Gangat N(2007)Leucocytosis in polycythemia vera predicts both inferior survival and leukaemic transformation Br J Haematol 138 354-358
  • [2] Strand J(2003)Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia Haematologica 88 13-18
  • [3] Li CY(2002)Myelofibrosis with myeloid metaplasia following essential thrombocythemia: actuarial probability, presenting characteristics and evolution in a series of 195 patients Br J Haematol 118 786-790
  • [4] Wu W(2008)20+ yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosis Eur J Haematol 80 386-390
  • [5] Pardanani A(1999)Histochemistry and morphometry on bone marrow biopsies in chronic myeloproliferative disorders—aids to diagnosis and classification Ann Hematol 78 495-506
  • [6] Tefferi A(2004)Myelofibrosis with myeloid metaplasia: new developments in pathogenesis and treatment Intern Med 43 540-547
  • [7] Passamonti F(1982)Fibrous hematopoietic tumors arising in agnogenic myeloid metaplasia Hum Pathol 13 804-810
  • [8] Malabarba L(1973)Myeloid metaplasia with myelofibrosis. The clinical spectrum of extramedullary hematopoiesis and tumor formation Johns Hopkins Med J 132 253-270
  • [9] Orlandi E(2000)Myelofibrosis with myeloid metaplasia N Engl J Med 342 1255-1265
  • [10] Barate C(1965)Extramedullary myeloid tumors in primary myelofibrosis Cancer 18 727-736